Baseline thymic volume is a predictor for CD4 T cell repopulation in adult HIV-infected patients under highly active antiretroviral therapy

Antiviral Therapy

Volumn 7, Issue 3, 2002, Pages 159-163

  De la Rosa, Rafael ^a   Leal, Manuel ^a   Rubio, Amalia ^a   Martinez Moya, Manuel ^a   Delgado, Juan ^a   Ruiz Mateos, Ezequiel ^a   Merchante, Elena ^a   Sánchez Quijano, Armando ^a   Lissen, Eduardo ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG SCINTISCANNING; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; T LYMPHOCYTE SUBPOPULATION; THYMUS;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; ORGAN SPECIFICITY; THYMUS GLAND;

EID: 0036768080     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, Holmberg S & Jones JL. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clinical Infectious Diseases 2000; Suppl 1:S5-S14.
2. Palella FJ, Delaney K, Moorman A, Loveless MO, Fuhrer J, Satten GA, Aschman DJ & Holmberg SD. Declining morbidity and mortality among patients with advanced immunodeficiency virus infection. New England Journal of Medicine 1998; 338:853-860.
3. Piketty C, Castiel P, Belec L, Si Mohamed A, Gilquin J, González-Canali G, Jayle D, Karmochkine M, Weiss L, Aboulker JP & Kazatchkine MD. Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease. AIDS 1998; 12:745-750.
4. Lederman MM, Connick E, Landay A, Kuritzkes DR, Spritzler J, St Clair M, Kotzin BL, Fox L, Chiozi MH, Leonard JM, Rousseau F, Waid M, Roe JD, Martínez A & Kessler H. Immunologic response associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine and ritonavir. Journal of Infectious Diseases 1998; 178:70-79.
5. Connick E, Lederman MM, Kotzin BL, Spritzler J, Kuritzkes DR, St Clair M, Savin AD, Fox L, Chiozzi MH, Leonard JM, Rousseau F, Dárc Roe J, Martínez A, Kessler H & Landay A. Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response. Journal of Infectious Diseases 2000; 181:358-363.
6. Wu H, Kuritzkes DR, McClernon DR, Kessler H, Connick E, Landay A, Spear G, Heath-Chiozzi M, Rousseau F, Fox L, Spritzler J, Leonard JM & Lederman MM. Characterization of viral dynamics in human immunodeficiency virus type-1 infected patients treated with combination antiretroviral therapy. Journal of Infectious Diseases 1999; 179:799-807.
7. Viard JP, Mocroft A, Chiesi A, Kirk O, Roge B, Panos G, Vetter N, Bruun JN & Johnson M. Influence of age on CD4 cell recovery in human immunodeficiency virusinfected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. Journal of Infectious Diseases 2001; 183:1290-1294.
8. McCune JM, Loftus R, Schmidt DK, Carrol P, Webster D, Swor-Yim LB, Francis IR, Gross BH & Grant RM. High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. Journal of Clinical Investigation 1998; 101:2301-2308.
9. Douek DC, McFarland RD, Keisser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL, Jameson BD, Zack JA, Picker LJ & Koup RA. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998; 396:690-695.
10. Choyke PL, Zeman RK, Gootenberg JE, Greenberg JN, Hoffer F & Frank JA. Thymic atrophy and regrowth in response to chemotherapy: CT evaluation. American Journal of Roentgenology 1987; 149:269-272.
11. Friedman MA, Resser KJ, Marcus FS, Moss AA & Cann CE. How accurate are computed tomographic scans in assessment of changes in tumor size? American Journal of Medicine 1983; 75:193-198.
12. Lecossier D, Bouchonnet F, Scneider P, Clavel F & Hance AJ. Discordant increases in CD4+ T cells in human immunodeficiency virus-infected patients experiencing virologic treatment failure: role of thymic output and T cell death. Journal of Infectious Diseases 2001; 183:1009-1016.
13. Smith KY, Valdez H, Landay A, Spritzler J, Kessler HA, Connick E, Kuritzkes D, Gross B, Francis I, McCune JM & Lederman MM. Thymic size and lymphocite restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy. Journal of Infectious Diseases 2000; 181:141-147.
14. Texeira L, Valdez H, McCune J, Koup RA, Badley AD, Hellerstein MK, Napolitano LA, Douek DC, Mbisa G, Deeks S, Harris JM, Barbour JD, Gross BH, Francis IR, Halvorsen R, Asaad R & Lederman MM. Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS 2001; 15:1749-1756.
15. Knobel H, Guelar A, Valdecillo G, Carmona A, González A, López-Colomés JL, Saballs P, Gimeno JL & Díez A. Response to highly active antiretroviral therapy in HIV infected patients aged 60 years or older after 24 months follow-up. AIDS 2001; 15:1591-1592.
16. Manfredi R, & Chiodo F. A case-control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age. AIDS 2000; 14:1475-1477.
17. Centers for Disease Control: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbility and Mortality Weekly Report 1992; 41:1-19.